🇺🇸 FDA
Patent

US 11840581

α4β7 thioether peptide dimer antagonists

granted A61KA61K38/00A61K38/12

Quick answer

US patent 11840581 (α4β7 thioether peptide dimer antagonists) held by Protagonist Therapeutics, Inc. expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Protagonist Therapeutics, Inc.
Grant date
Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K38/12, A61K47/54, A61K47/545